We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

70 hedge funds and large institutions have $268M invested in Collegium Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 8

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

17% more funds holding

Funds holding: 60 → 70 (+10)

18% less capital invested

Capital invested by funds: $327M → $268M (-$58.3M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
70
Holders Change
+10
Holders Change %
+16.67%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
18
Increased
38
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$14.5M
2
Franklin Resources
Franklin Resources
California
+$9.19M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$5.65M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$5.35M
5
HCMT
Highland Capital Management (Texas)
Texas
+$4.66M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$6.75M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.36M
3
Bank of America
Bank of America
North Carolina
-$1.11M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$358K
5
Renaissance Technologies
Renaissance Technologies
New York
-$328K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
26
Birchview Capital
Vermont
$1.39M +$327K +18,000 +31%
Ameriprise
27
Ameriprise
Minnesota
$1.38M +$1.38M +75,865 New
MIM
28
Monashee Investment Management
Massachusetts
$1.23M – – –
NC
29
NBW Capital
Massachusetts
$1.16M +$8.07K +444 +0.7%
Goldman Sachs
30
Goldman Sachs
New York
$1.09M +$354K +19,460 +48%
NIP
31
Nicholas Investment Partners
California
$849K +$850K +46,773 New
TAM
32
Tocqueville Asset Management
New York
$797K -$216K -11,900 -21%
RJA
33
Raymond James & Associates
Florida
$747K +$748K +41,175 New
Wellington Management Group
34
Wellington Management Group
Massachusetts
$629K +$631K +34,700 New
MWP
35
MYCIO Wealth Partners
Pennsylvania
$597K +$398K +21,901 +199%
Macquarie Group
36
Macquarie Group
Australia
$551K +$552K +30,353 New
Morgan Stanley
37
Morgan Stanley
New York
$501K +$38.2K +2,101 +8%
BIM
38
BlackRock Investment Management
Delaware
$475K +$30.2K +1,660 +7%
TCIM
39
TIAA CREF Investment Management
New York
$426K -$86.8K -4,774 -17%
RFC
40
Russell Frank Company
Washington
$422K -$212K -11,659 -33%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$352K +$174K +9,579 +98%
ProShare Advisors
42
ProShare Advisors
Maryland
$332K +$12.9K +708 +4%
PPA
43
Parametric Portfolio Associates
Washington
$325K +$326K +17,927 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$293K +$68.3K +3,755 +30%
M&T Bank
45
M&T Bank
New York
$287K +$288K +15,820 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$205K +$182K +10,036 +794%
TA
47
Teachers Advisors
New York
$204K +$29.1K +1,600 +17%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$172K +$184K +10,100 New
Citigroup
49
Citigroup
New York
$167K +$79.4K +4,367 +90%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$165K +$54.7K +3,008 +49%
1
2
3 4

COLL Hedge Fund Activity: Q1 2016 in Review

70 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2016, worth a combined $268M — down 18% from $327M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new COLL positions and 7 closed out — a net gain of 11 holders — while 38 added to existing stakes and 8 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $14.5M. The largest seller was RA Capital Management, cutting an estimated $6.75M.

  • 70 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2016, up from 60 in Q4 2015.
  • Funds reported $268M of Collegium Pharmaceutical stock for Q1 2016, down 18% quarter-over-quarter.
  • 18 funds opened new Collegium Pharmaceutical positions in Q1 2016 and 7 closed out, a net change of +11 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2016 was Eventide Asset Management, an estimated $14.5M added.
  • The largest Collegium Pharmaceutical seller in Q1 2016 was RA Capital Management, an estimated $6.75M sold.

Based on aggregated 13F filings for Q1 2016.